Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

The differential diagnosis includes squamous cell carcinoma ... 1987), and another died of a poorly differentiated carcinoma of the lung; again, unrelated to the PKMB (Bargman, 1985).